UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

Intestinal drug efflux: formulation and food effects

Advanced drug delivery reviews, 2001-10, Vol.50, p.S13-S31

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug

Advanced drug delivery reviews, 2007-07, Vol.59 (6), p.419-426

2007

Link zum Volltext

Verfügbarkeit prüfen

Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol

European Journal of Pharmaceutical Sciences, 2001-02, Vol.12 (4), p.361-367

2001

Link zum Volltext

Verfügbarkeit prüfen

Rate-limiting biotransformation of triamterene is mediated by CYP1A2

International journal of clinical pharmacology and therapeutics, 2005-07, Vol.43 (7), p.327

2005

Link zum Volltext

Verfügbarkeit prüfen

Nanosuspension formulations for low-soluble drugs : Pharmacokinetic evaluation using spironolactone as model compound

Drug development and industrial pharmacy, 2005-03, Vol.31 (3), p.319-329

2005

Link zum Volltext

Verfügbarkeit prüfen

Acyl glucuronides revisited : is the glucuronidation process a toxification as well as a detoxification mechanism ?

Drug metabolism reviews, 1992, Vol.24 (1), p.5-47

1992

Link zum Volltext

Verfügbarkeit prüfen

Concentration-Dependent Effect of Naringin on Intestinal Absorption of β₁-Adrenoceptor Antagonist Talinolol Mediated by P-Glycoprotein and Organic Anion Transporting Polypeptide (Oatp)

Pharmaceutical research, 2009-03, Vol.26 (3), p.560-567

2009

Link zum Volltext

Verfügbarkeit prüfen

Caco‐2 versus Caco‐2/HT29‐MTX Co‐cultured Cell Lines: Permeabilities Via Diffusion, Inside‐ and Outside‐Directed Carrier‐Mediated Transport

Journal of pharmaceutical sciences, 2000-01, Vol.89 (1), p.63-75

2000

Link zum Volltext

Verfügbarkeit prüfen

P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound

International journal of clinical pharmacology and therapeutics, 1998-01, Vol.36 (1), p.16

1998

Link zum Volltext

Verfügbarkeit prüfen

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds - implications for pharmacokinetics of selected substrates

Journal of pharmacy and pharmacology, 2004-08, Vol.56 (8), p.967-975

2004

Link zum Volltext

Verfügbarkeit prüfen

In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect

Pharmaceutical research, 2006-08, Vol.23 (8), p.1712-1720

2006

Link zum Volltext

Verfügbarkeit prüfen

Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?

European journal of pharmaceutical sciences, 2005-06, Vol.25 (2), p.263-271

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparative Pharmacodynamics and Pharmacokinetics of Candesartan and Losartan in Man

Journal of pharmacy and pharmacology, 2000-09, Vol.52 (9), p.1075-1083

2000

Link zum Volltext

Verfügbarkeit prüfen

Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites

International journal of clinical pharmacology and therapeutics, 2000-04, Vol.38 (4), p.168

2000

Link zum Volltext

Verfügbarkeit prüfen

P-Glycoprotein (P-gp) Mediated Efflux in Caco-2 Cell Monolayers: The Influence of Culturing Conditions and Drug Exposure on P-gp Expression Levels

Journal of pharmaceutical sciences, 1998-06, Vol.87 (6), p.757-762

1998

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells

Planta medica, 2007-01, Vol.73 (1), p.27-32

2007

Link zum Volltext

Verfügbarkeit prüfen

Role of P-glycoprotein-mediated secretion in absorptive drug permeability : An approach using passive membrane permeability and affinity to P-glycoprotein

Journal of pharmaceutical sciences, 1999-10, Vol.88 (10), p.1067-1072

1999

Link zum Volltext

Verfügbarkeit prüfen

Dimeric 4-aryl-1,4-dihydropyridines as novel HIV-1 protease inhibitors : affinities to intestinal P-glycoprotein

Pharmazie, 2000-10, Vol.55 (10), p.784-785

2000

Link zum Volltext

Verfügbarkeit prüfen

The influence of age on the pharmacokinetics and pharmacodynamics of bemetizide and triamterene: a single and multiple dose study

Archives of gerontology and geriatrics, 2001-06, Vol.32 (3), p.265-273

2001

Link zum Volltext

Verfügbarkeit prüfen

Covalent binding of acidic drugs via reactive intermediates : detection of benoxaprofen and flunoxaprofen protein adducts in biological material

Pharmazie, 1996-11, Vol.51 (11), p.874-881

1996

Link zum Volltext

Verfügbarkeit prüfen

Lipophilicities of baclofen ester prodrugs correlate with affinities to the ATP-dependent efflux pump P-glycoprotein: Relevance for their permeation across the blood-brain barrier?

Pharmaceutical research, 2003-05, Vol.20 (5), p.772-778

2003

Link zum Volltext

Verfügbarkeit prüfen

Saturable Enantioselective First-pass Effect for Carvedilol after High Oral Racemate Doses in Rats

Archiv der Pharmazie (Weinheim), 1993, Vol.326 (3), p.123-125

1993

Link zum Volltext

Verfügbarkeit prüfen

In vivo non-linear intestinal permeability of celiprolol and propranolol in conscious dogs: evidence for intestinal secretion

European journal of pharmaceutical sciences, 1998, Vol.6 (1), p.75-81

1998

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats

European journal of pharmaceutical sciences, 2001-02, Vol.12 (4), p.405-415

2001

Link zum Volltext

Verfügbarkeit prüfen

HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats

Journal of pharmaceutical and biomedical analysis, 1998, Vol.16 (5), p.863-873

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(91)

Sprache

Englisch
(89)
Japanisch
(11)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(57)
Humans
(56)
Biological And Medical Sciences
(54)
Medical Sciences
(51)
Pharmacology. Drug Treatments
(51)
Pharmacology & Pharmacy
(50)
Chemistry
(30)
Male
(30)
Physical Sciences
(30)
Animals
(26)
General Pharmacology
(25)
Chromatography, High Pressure Liquid
(20)
Stereoisomerism
(20)
Chemistry, Medicinal
(18)
Chemistry, Multidisciplinary
(18)
Rats
(17)
Adult
(12)
Chemistry, Analytical
(12)
Glucuronates - Metabolism
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intestinal drug efflux: formulation and food effects

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug

Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol

Rate-limiting biotransformation of triamterene is mediated by CYP1A2

Nanosuspension formulations for low-soluble drugs : Pharmacokinetic evaluation using spironolactone as model compound

Acyl glucuronides revisited : is the glucuronidation process a toxification as well as a detoxification mechanism ?

Concentration-Dependent Effect of Naringin on Intestinal Absorption of β₁-Adrenoceptor Antagonist Talinolol Mediated by P-Glycoprotein and Organic Anion Transporting Polypeptide (Oatp)

Caco‐2 versus Caco‐2/HT29‐MTX Co‐cultured Cell Lines: Permeabilities Via Diffusion, Inside‐ and Outside‐Directed Carrier‐Mediated Transport

P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds - implications for pharmacokinetics of selected substrates

In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect

Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?

Comparative Pharmacodynamics and Pharmacokinetics of Candesartan and Losartan in Man

Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites

P-Glycoprotein (P-gp) Mediated Efflux in Caco-2 Cell Monolayers: The Influence of Culturing Conditions and Drug Exposure on P-gp Expression Levels

Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells

Role of P-glycoprotein-mediated secretion in absorptive drug permeability : An approach using passive membrane permeability and affinity to P-glycoprotein

Dimeric 4-aryl-1,4-dihydropyridines as novel HIV-1 protease inhibitors : affinities to intestinal P-glycoprotein

The influence of age on the pharmacokinetics and pharmacodynamics of bemetizide and triamterene: a single and multiple dose study

Covalent binding of acidic drugs via reactive intermediates : detection of benoxaprofen and flunoxaprofen protein adducts in biological material

Lipophilicities of baclofen ester prodrugs correlate with affinities to the ATP-dependent efflux pump P-glycoprotein: Relevance for their permeation across the blood-brain barrier?

Saturable Enantioselective First-pass Effect for Carvedilol after High Oral Racemate Doses in Rats

In vivo non-linear intestinal permeability of celiprolol and propranolol in conscious dogs: evidence for intestinal secretion

Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats

HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats

Suchergebnisse filtern